Literature DB >> 15877783

Cost of Parkinson's disease in Europe.

P Lindgren1, S von Campenhausen, Ea Spottke, U Siebert, R Dodel.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 15877783     DOI： 10.1111/j.1468-1331.2005.01197.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN： 1351-5101            Impact factor:   6.089


× No keyword cloud information.
  18 in total

Review 1.  Cost effectiveness of pharmacotherapies in early Parkinson's disease.

Authors:  Karla M Eggert; Jens P Reese; Wolfgang H Oertel; Richard Dodel
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

2.  Costs of illness in a Russian cohort of patients with Parkinson's disease.

Authors:  Yaroslav Winter; Sonja von Campenhausen; Georgy Popov; Jens P Reese; Jens Klotsche; Kai Bötzel; Eugene Gusev; Wolfgang H Oertel; Richard Dodel; Alla Guekht
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

Review 3.  Stem Cell Transplantation and Physical Exercise in Parkinson's Disease, a Literature Review of Human and Animal Studies.

Authors:  Jaison Daniel Cucarián Hurtado; Jenny Paola Berrío Sánchez; Ramiro Barcos Nunes; Alcyr Alves de Oliveira
Journal:  Stem Cell Rev Rep       Date:  2018-04       Impact factor: 5.739

4.  Real life cost and quality of life associated with continuous intraduodenal levodopa infusion compared with oral treatment in Parkinson patients.

Authors:  Christofer Lundqvist; Antonie Giæver Beiske; Ola Reiertsen; Ivar Sønbø Kristiansen
Journal:  J Neurol       Date:  2014-10-01       Impact factor: 4.849

5.  Treatment of Parkinson's disease: a survey of patients and neurologists.

Authors:  Matthias Fargel; Bernd Grobe; Eberhard Oesterle; Claudia Hastedt; Markus Rupp
Journal:  Clin Drug Investig       Date:  2007       Impact factor: 2.859

6.  [Prospective study of the direct and indirect costs of idiopathic Parkinson's disease].

Authors:  I Dengler; N Leukel; T Meuser; W H Jost
Journal:  Nervenarzt       Date:  2006-10       Impact factor: 1.214

7.  Social and clinical determinants of quality of life in Parkinson's disease in Austria: a cohort study.

Authors:  Yaroslav Winter; Sonja von Campenhausen; Julia Gasser; Klaus Seppi; Jens-P Reese; Karl-P Pfeiffer; Kai Bötzel; Wolfgang H Oertel; Richard Dodel; Werner Poewe
Journal:  J Neurol       Date:  2009-11-28       Impact factor: 4.849

8.  [Cost of illness and health service patterns in Morbus Parkinson in Austria].

Authors:  Sonja von Campenhausen; Yaroslav Winter; Julia Gasser; Klaus Seppi; Jens-P Reese; Karl-P Pfeiffer; Sabine Geiger-Gritsch; Kai Bötzel; Uwe Siebert; Wolfgang H Oertel; Richard Dodel; Werner Poewe
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

9.  Positron emission tomography imaging demonstrates correlation between behavioral recovery and correction of dopamine neurotransmission after gene therapy.

Authors:  Ludovic Leriche; Tomas Björklund; Nathalie Breysse; Laurent Besret; Marie-Claude Grégoire; Thomas Carlsson; Frédéric Dollé; Ronald J Mandel; Nicole Déglon; Philippe Hantraye; Deniz Kirik
Journal:  J Neurosci       Date:  2009-02-04       Impact factor: 6.167

10.  Continuous levodopa for advanced Parkinson's disease.

Authors:  Christofer Lundqvist
Journal:  Neuropsychiatr Dis Treat       Date:  2007-06       Impact factor: 2.570
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.